BiKE treatment led to a significant increase in mobilization of CD107+ cytotoxic granula in NK cells from healthy volunteers against primary ALL and AML blasts, underlining the insufficient antileukemic function of NK cells without BiKE treatment. The gene discussed is BMP2K; the disease is acute lymphoblastic leukemia.